Before the discoveries that could lead to biofilm eradication, before the idea that he was even working on treatments for the bacterial communities that are crucial to most human infections, Steven Goodman, PhD, had a mystery on his hands. For nearly 15 years. Dr. Goodman, then a biochemist at the University of Southern California’s Herman Ostrow School of Dentistry, found a certain group of...
Post
Cancer Cells Destroyed with Dinosaur Extinction Metal
*Cancer cells can be killed with metal from the asteroid that killed the dinosaurs, thanks to new research from University of Warwick UK and Sun-Yat Sen University in China This is an artist´s impression of a dinosaur *Compound based on iridium kills cancer cells by filling them with deadly version of oxygen when activated by...
Post
Promising new drug for hepatitis B tested
Dr. Robert Lanford works in his lab at Texas Biomed. Research at the Southwest National Primate Research Center (SNPRC) on the campus of Texas Biomedical Research Institute helped advance a new treatment now in human trials for chronic hepatitis B virus (HBV) infection. Testing at SNPRC provided proof this novel therapeutic approach and drug...
Post
New system for treating colorectal cancer can lead to complete cure
Novel three-step pretargeted radioimmunotherapy offers safe, effective treatment RESTON, Va. – Researchers at Memorial Sloan Kettering Cancer Center in New York City and Massachusetts Institute of Technology in Boston have developed a new, three-step system that uses nuclear medicine to target and eliminate colorectal cancer. In this study with a mouse model, researchers achieved a...
Post
Scientists discover potential treatment to stop glaucoma in its tracks
Retinal ganglion cells (green) connecting with astrocytes (red) and blood cells (white) in the inner retina. Vision scientists at the University of California, Berkeley, and the University of Toronto have discovered that naturally occurring molecules known as lipid mediators have the potential to halt the progression of glaucoma, the world’s second-leading cause of blindness....
Post
Researcher draws bulls eye around muscular dystrophy drug targets
Francis M. Sverdrup, Ph.D., research fellow in the Saint Louis University Department of Biochemistry and Molecular Biology. In a recent paper published in the journal Skeletal Muscle, a Saint Louis University researcher reports success in identifying new drug targets that potentially could slow or halt the progression of a form muscular dystrophy, an illness characterized...
Post
Flavonoid derivatives targeting NF-kappaB
The aim of the study was to develop new synthetic anti-inflammatory and cytotoxic agents targeting NF-kappaB Nuclear factor-kappaB (NF-kappaB) has been reported to regulate various genes involved in cancer and inflammation. Accordingly, drugs inhibiting NF-kappaB may possess both anti-inflammatory and anticancer properties. So there is a need to discover novel compounds which should not only...
Post
FDA warns against marijuana ‘cancer cures’: Agency slams four companies for ‘duping customers with false promises’
The FDA has sent letter to four companies selling CBD oil in California, Florida and Colorado All four companies claim their products help shrink and beat tumors The FDA is cracking down on marijuana products marketed as cancer cures. The agency has sent a letter to four companies, slamming their unsubstantiated promises that patients can treat life-threatening...
Post
More than a quarter of patients with a common type of deadly brain tumor were alive 3 years after undergoing new gene therapy, promising clinical trial reveals
Results were found after treating patients with recurrent high-grade glioma, the most common type of adult brain tumor It’s the type US Senator John McCain was diagnosed with earlier this year The cancer infiltrates into the normal brain tissue and is often incurable Median survival was 14.4 months, compared with 8 months typically seen New...
Post
New database to connect neurodegenerative disease community
Researchers studying neurodegenerative disease can now look up cohort studies and make connections through a new online database. The JPND Global Cohort Portalopens in new window, created by the EU Joint Programme in Neurodegenerative Disease Research (JPND) for which the MRC is a founder member, is a searchable online database of neurodegenerative disease cohort studies. Long-term...